Since resTORbio Inc. (NASDAQ:TORC) and Anika Therapeutics Inc. (NASDAQ:ANIK) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation of both companies.
Earnings and Valuation
Table 1 highlights resTORbio Inc. and Anika Therapeutics Inc.s gross revenue, earnings per share (EPS) and valuation.
Profitability
Table 2 provides us resTORbio Inc. and Anika Therapeutics Inc.s return on equity, return on assets and net margins.
Liquidity
31.4 and 31.4 are the respective Current Ratio and a Quick Ratio of resTORbio Inc. Its rival Anika Therapeutics Inc.s Current and Quick Ratios are 18.1 and 16.1 respectively. resTORbio Inc. has a better chance of clearing its pay short and long-term debts than Anika Therapeutics Inc.
Analyst Ratings
The following table delivered below contains the ratings and recommendations for resTORbio Inc. and Anika Therapeutics Inc.
The consensus price target of resTORbio Inc. is $23, with potential upside of 215.93%.
Institutional & Insider Ownership
The shares of both resTORbio Inc. and Anika Therapeutics Inc. are owned by institutional investors at 54.1% and 96.6% respectively. 38.1% are resTORbio Inc.s share held by insiders. Insiders Comparatively, held 0.9% of Anika Therapeutics Inc. shares.
Performance
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year resTORbio Inc. was less bullish than Anika Therapeutics Inc.
Summary
Anika Therapeutics Inc. beats resTORbio Inc. on 7 of the 12 factors.
resTORbio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. Its lead program is targeting the selective inhibition of TORC1, an evolutionary conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiac, and neurologic systems. The company's lead drug candidate RTB101 is a selective, orally administered, TORC1 inhibitor, which is being tested in a Phase 2b clinical trial as a first in-class immunotherapy for reducing the incidence of respiratory tract infections in the elderly by enhancing the function of the immune system. It also intends to develop RTB101 for additional aging-related indications, such as heart failure or neurodegenerative diseases. The company was founded in 2016 and is based in Boston, Massachusetts.
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a woven gauze used as a bone graft wrap; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The companys dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; INCERT, a HA product used for the prevention of post-surgical spinal adhesions; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
Here is the original post:
Reviewing resTORbio Inc. (TORC)'s and Anika Therapeutics Inc. (NASDAQ:ANIK)'s results - MS Wkly
- Cardiac Regeneration - Center for Regenerative Medicine - Mayo Clinic ... [Last Updated On: April 11th, 2018] [Originally Added On: April 11th, 2018]
- Cardiac Regeneration - Mayo Clinic [Last Updated On: April 22nd, 2018] [Originally Added On: April 22nd, 2018]
- Materials - MDPI [Last Updated On: May 18th, 2018] [Originally Added On: May 18th, 2018]
- Cardiac Stem Cell Research - Cedars-Sinai [Last Updated On: May 22nd, 2018] [Originally Added On: May 22nd, 2018]
- Cardiac regeneration: current therapiesfuture concepts ... [Last Updated On: May 26th, 2018] [Originally Added On: May 26th, 2018]
- Cardiac Regeneration - Victor Chang Cardiac Research Institute [Last Updated On: May 30th, 2018] [Originally Added On: May 30th, 2018]
- Cardiology Conferences | Cardio 2018 Events | Cardiac ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Laboratory for Cardiac Regeneration | Baylor College of ... [Last Updated On: June 18th, 2018] [Originally Added On: June 18th, 2018]
- Regeneration of Muscle [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- Regeneration of Muscle - eLS: Essential for Life Science [Last Updated On: July 14th, 2018] [Originally Added On: July 14th, 2018]
- Cardiac Repair and Regeneration Research Unit | Heart and ... [Last Updated On: July 25th, 2018] [Originally Added On: July 25th, 2018]
- Myogenesis - Wikipedia [Last Updated On: August 8th, 2018] [Originally Added On: August 8th, 2018]
- Regeneration (biology) - Wikipedia [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- World Cardiology and Cardiologist Meeting [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- Cardiac (comics) - Wikipedia [Last Updated On: August 26th, 2018] [Originally Added On: August 26th, 2018]
- Cardiac regeneration and repair - 1st Edition - Elsevier [Last Updated On: September 21st, 2018] [Originally Added On: September 21st, 2018]
- Post-doc position available cardiac regeneration ... [Last Updated On: September 29th, 2018] [Originally Added On: September 29th, 2018]
- UW Bioengineering: Building World Leadership in Heart ... [Last Updated On: September 29th, 2018] [Originally Added On: September 29th, 2018]
- Cardiac Regeneration - What Science Can Do - AstraZeneca [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Cardiac Regeneration, Stem Cells | Research | Baylor ... [Last Updated On: November 30th, 2018] [Originally Added On: November 30th, 2018]
- Cardiac Regeneration - Victor Chang Institute [Last Updated On: December 6th, 2018] [Originally Added On: December 6th, 2018]
- Entering a new era in vascular and cardiac regeneration ... [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Cardiac regeneration and repair - 1st Edition [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Heart Regeneration Technologies [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Cardiac Regeneration - Center for Regenerative Medicine ... [Last Updated On: December 19th, 2018] [Originally Added On: December 19th, 2018]
- Zebrafish Heart Regeneration | HHMI BioInteractive [Last Updated On: December 22nd, 2018] [Originally Added On: December 22nd, 2018]
- Rapid cell regeneration - Heroes Wiki [Last Updated On: December 22nd, 2018] [Originally Added On: December 22nd, 2018]
- Cardiac muscle - Wikipedia [Last Updated On: December 23rd, 2018] [Originally Added On: December 23rd, 2018]
- Cardiac regeneration in and : discrepancies and problems ... [Last Updated On: January 8th, 2019] [Originally Added On: January 8th, 2019]
- OHSU Center for Regenerative Medicine Heart Regeneration ... [Last Updated On: January 8th, 2019] [Originally Added On: January 8th, 2019]
- Dr. Sanjiv Dhingra, Cardiac Regeneration and Tissue ... [Last Updated On: January 30th, 2019] [Originally Added On: January 30th, 2019]
- Mending a Broken Heart: Stem Cells and Cardiac Repair ... [Last Updated On: February 20th, 2019] [Originally Added On: February 20th, 2019]
- Cardiac Repair and Regeneration | Division of Cardiology ... [Last Updated On: February 20th, 2019] [Originally Added On: February 20th, 2019]
- Stem Cell Therapy and Stem Cell Injection Provider Finder ... [Last Updated On: March 5th, 2019] [Originally Added On: March 5th, 2019]
- KearnsSayre syndrome - Wikipedia [Last Updated On: March 8th, 2019] [Originally Added On: March 8th, 2019]
- Ruohola-Baker Lab [Last Updated On: March 15th, 2019] [Originally Added On: March 15th, 2019]
- MTS Science [Last Updated On: May 3rd, 2019] [Originally Added On: May 3rd, 2019]
- New Insights Into the Healing Capacity of the Heart: The Hippo Pathway - Cath Lab Digest [Last Updated On: September 26th, 2019] [Originally Added On: September 26th, 2019]
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- The nanoengineer working to mend broken hearts - UNSW Newsroom [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- New insights into heart's healing capacity - Baylor College of Medicine News [Last Updated On: September 29th, 2019] [Originally Added On: September 29th, 2019]
- Tenaya Therapeutics Closes $92 Million Series B Financing - BioSpace [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- Regenerative medicine today: Are diabetes and vascular disease treatments ready for the clinic? - Science Magazine [Last Updated On: October 5th, 2019] [Originally Added On: October 5th, 2019]
- TAMassociati: the new Church of the Resurrection in Varignano - Floornature.com [Last Updated On: October 14th, 2019] [Originally Added On: October 14th, 2019]
- What the Hippo pathway in cardiac fibroblasts reveals about heart function - Baylor College of Medicine News [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Capricor Therapeutics to Host Key Opinion Leader Call on the Role of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy (DMD) - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Regenerative Medicine Market Industry Outlook, Growth Prospects and Key Opportunities - Health News Office [Last Updated On: October 24th, 2019] [Originally Added On: October 24th, 2019]
- Ottawa-based treatment a leap forward in addressing heart failure - Winnipeg Sun [Last Updated On: October 27th, 2019] [Originally Added On: October 27th, 2019]
- Global Regenerative Medicines Market Demand Analysis & Opportunity Evaluation Report 2019-2027 with Focus on U.S. & Europe -... [Last Updated On: November 15th, 2019] [Originally Added On: November 15th, 2019]
- The Heart of the Matter: Leveraging Advances in Cardiac Biology to Innovate Gene-Based Therapies for Heart Failure - Physician's Weekly [Last Updated On: November 15th, 2019] [Originally Added On: November 15th, 2019]
- SANUWAVE Health Reports Third Quarter 2019 Financial Results Other OTC:SNWV - GlobeNewswire [Last Updated On: November 16th, 2019] [Originally Added On: November 16th, 2019]
- Moderna: Undervalued As The Promising Pipeline Awaits Collaborations - Seeking Alpha [Last Updated On: November 23rd, 2019] [Originally Added On: November 23rd, 2019]
- Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells Derived from Adipose Tissue and Bone Marrow on Acute Myocardial Infarction... [Last Updated On: November 23rd, 2019] [Originally Added On: November 23rd, 2019]
- Stem Cell Therapy May Improve Heart Health In New Ways - TheHealthMania [Last Updated On: December 5th, 2019] [Originally Added On: December 5th, 2019]
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace [Last Updated On: December 9th, 2019] [Originally Added On: December 9th, 2019]
- Polymeric Biomaterials Market Trends Analysis Forecast to 2019-2024 |Evolving Industry Overview by Types, Applications, Size & Share - Sino News... [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- SMD - Researchers look behind the biological curtain on how fish oil might fight inflammatory disease - QMUL [Last Updated On: December 16th, 2019] [Originally Added On: December 16th, 2019]
- Suspended animation, you say? The biggest and freakiest scientific breakthroughs of 2019 - SYFY WIRE [Last Updated On: December 29th, 2019] [Originally Added On: December 29th, 2019]
- 2019: Year in Pictures by Robert Cohen | Metro - STLtoday.com [Last Updated On: December 31st, 2019] [Originally Added On: December 31st, 2019]
- MicroCures Announces Issuance of New Patent Covering First-of-its-Kind Cell Movement Decelerator Technology with Potential Applications in Oncology... [Last Updated On: January 15th, 2020] [Originally Added On: January 15th, 2020]
- Cells that regenerate heart in zebrafish discovered - Biology Reporter [Last Updated On: February 7th, 2020] [Originally Added On: February 7th, 2020]
- SANUWAVE Health Appoints Dr. Tom Price to Its Board of Directors - Yahoo Finance [Last Updated On: February 7th, 2020] [Originally Added On: February 7th, 2020]
- Capricor Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update - Associated Press [Last Updated On: March 19th, 2020] [Originally Added On: March 19th, 2020]
- Researchers and Doctors alike pursuing the field of stem cell research in treating heart attack survivors - Medical Herald [Last Updated On: March 19th, 2020] [Originally Added On: March 19th, 2020]
- Artificial Heart Lung Machines Market report reviews opportunities and analysis by size, share, trends, manufacturer, forecast 2020-2026 - WhaTech... [Last Updated On: April 29th, 2020] [Originally Added On: April 29th, 2020]
- Scientists have figured out how to make the heart to regenerate - The Times Hub [Last Updated On: April 29th, 2020] [Originally Added On: April 29th, 2020]
- Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat dietinduced obesity - Science Advances [Last Updated On: May 9th, 2020] [Originally Added On: May 9th, 2020]
- SANUWAVE HEALTH : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com [Last Updated On: May 15th, 2020] [Originally Added On: May 15th, 2020]
- SANUWAVE Health to Hold First Quarter Financial Results and Business Update Call on Monday, May 18, 2020 - Yahoo Finance [Last Updated On: May 15th, 2020] [Originally Added On: May 15th, 2020]
- SANUWAVE Health to Hold Investor Live Webcast on Wednesday, June 10, 2020 - Yahoo Finance [Last Updated On: June 10th, 2020] [Originally Added On: June 10th, 2020]
- SANUWAVE Health Enters Into Exclusive Letter of Intent to Acquire Celularity's UltraMIST and Exclusive Partnership Rights for Wound Care Biologic... [Last Updated On: June 11th, 2020] [Originally Added On: June 11th, 2020]
- SANUWAVE Health, Inc. Discusses The Potential of Their Celularity Acquisition with The Stock Day Podcast (SNWV) July 1, 2020 - Stock Day Media [Last Updated On: July 1st, 2020] [Originally Added On: July 1st, 2020]
- Interim Analysis of Recardio's Phase II Clinical Trial to Be Presented at the 2020 Congress of the European Society of Cardiology - PRNewswire [Last Updated On: July 1st, 2020] [Originally Added On: July 1st, 2020]
- Growth and demand of Plasma Therapy in the Asia Pacific Region available in the latest report - WhaTech Technology and Markets News [Last Updated On: July 4th, 2020] [Originally Added On: July 4th, 2020]
- Plasma Therapy Market Size by Top Companies, Regions, Types and Application, End Users and Forecast to 2027 - Bulletin Line [Last Updated On: August 14th, 2020] [Originally Added On: August 14th, 2020]
- Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen for Vascular Repair - BioSpace [Last Updated On: August 14th, 2020] [Originally Added On: August 14th, 2020]
- Polymeric Biomaterials Market Insights by Current Trends 2020 Future Demand by Top Key Players, Regions, Industry Size, and Business Strategy... [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- CORRECTION - SANUWAVE Health Announces Reimbursement Coverage for BIOVANCE From Largest Medicare and Medicaid Administrator in U.S. - Stockhouse [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- New Research Paper Suggests RegeneRx's Thymosin Beta 4 May be Useful in Treating COVID-19 - PRNewswire [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]
- To Repair a Damaged Heart, Three Cells are Better Than One - SDSU Newscenter [Last Updated On: September 11th, 2020] [Originally Added On: September 11th, 2020]